Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma.

Awad, Basma; Hamza, Alaaeldin Ahmed; Al-Maktoum, Amna; Al-Salam, Suhail; Amin, Amr

Awad, Basma; Hamza, Alaaeldin Ahmed; Al-Maktoum, Amna; Al-Salam, Suhail; Amin, Amr.

Afiliação

Awad B; Biology Department, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Hamza AA; National Organization for Drug Control and Research, Giza 12611, Egypt.
Al-Maktoum A; National Committee for Biochemistry and Molecular Biology and Medical Research Council, Academy of Scientific Research, Cairo 11334, Egypt.
Al-Salam S; Biology Department, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Amin A; Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

Cancers (Basel) ; 15(16)2023 Aug 11.

Article em En | MEDLINE | ID: mdl-37627094

Palavras-chave

apoptosis; crocin; hepatocellular carcinoma; inflammation; sorafenib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google